Edvenswa Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 12-12-2024
- Paid Up Capital ₹ 0.10 M
as on 12-12-2024
- Company Age 3 Year, 4 Days
- Last Filing with ROC 31 Mar 2024
About Edvenswa Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Uppuluri Anupama, Basavaraju Ratnakar, and Sreenivasa Uppuluri serve as directors at the Company.
- CIN/LLPIN
U24299TG2021PTC157996
- Company No.
157996
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Dec 2021
- Date of AGM
02 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Rangareddy, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Edvenswa Pharmaceuticals?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Uppuluri Anupama  | Director | 16-Dec-2021 | Current |
| Basavaraju Ratnakar | Director | 16-Dec-2021 | Current |
| Sreenivasa Uppuluri | Director | 16-Dec-2021 | Current |
Financial Performance and Corporate Structure Insights of Edvenswa Pharmaceuticals.
Enhance accessibility to Edvenswa Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Edvenswa Pharmaceuticals?
Unlock access to Edvenswa Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Edvenswa Tech Private LimitedActive 17 years 6 monthsUppuluri Anupama and Basavaraju Ratnakar are mutual person
Omni Healthcare Solutions Private LimitedActive 8 years 4 monthsUppuluri Anupama is a mutual person
- Edvenswa Consultancy Services Private LimitedActive 3 years 1 month
Sreenivasa Uppuluri is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Edvenswa Pharmaceuticals?
Edvenswa Pharmaceuticals has a workforce of 0 employees as of Mar 22, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Edvenswa Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Edvenswa Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
